Andrew D. Ashe - 02 Dec 2021 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VERV	Common Stock	Purchase	$128,420	+4,000	+2.4%	$32.10	170,722	02 Dec 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $31.93 to $32.12 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

President, Chief Operating Officer